颜红兵,周鹏

• 1:中国医学科学院 北京协和医学院 国家心血管病中心 阜外心血管病医院冠心病中心

摘要(Abstract)：

<正>2014年8月30日欧洲心脏病学会(ESC)和欧洲心胸外科协会(EACTS)在线发表了《2014年ESC/EACTS心肌血运重建治疗指南》[1-2]。新版指南在全面和系统复习了100项临床试验93 553例患者(随访262 090例患者-年)的基础上,对《2010年ESC/EACTS心肌血运重建治疗指南》[3]进行了7大修订,其中1大修订是将接受新一代药物洗脱支架(DES)的稳定性冠状动脉疾病患者的双联抗血

关键词(KeyWords)： 冠状动脉支架置入术;双联抗血小板;心肌血运重建

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 颜红兵,周鹏

参考文献(References)：

• [1]Windecker S,Kolh P,Alfonso F,et al.2014 ESC/EACTS Guidelines on myocardial revascularization:The Task Force on Myocardial Revascularization of the European Society of Cardiology(ESC)and the European Association for CardioThoracic Surgery(EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions(EAPCI).Eur Heart J,2014,35:2541-2619.
• [2]颜红兵,赵汉军,宋莉,等.欧洲冠状动脉血运重建治疗指南(2014年版).1版.北京:中国环境科学出版社,2014.
• [3]Wijns W,Kolh P,Danchin N,et al.Guidelines on myocardial revascularization:The Task Force on Myocardial Revascularization of the European Society of Cardiology(ESC)and the European Association for Cardio-Thoracic Surgery(EACTS).Eur Heart J,2010,31:2501-2555.
• [4]Valgimigli M,Campo G,Monti M,et al.Short-versus long-term duration of dual-antiplatelet therapy after coronary stenting:a randomized multicenter trial.Circulation,2012,125:2015-2026.
• [5]Valgimigli M,Borghesi M,Tebaldi M,et al.Should duration of dual antiplatelet therapy depend on the type and/or potency of implanted stent?A pre-specified analysis from the PROlonging Dual antiplatelet treatment after Grading stent-induced Intimal hyperplasia stud Y(PRODIGY).Eur Heart J,2013,34:909-919.
• [6]Gwon HC,Hahn JY,Park KW,et al.Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents:the Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting(EXCELLENT)randomized,multicenter study.Circulation,2012,125:505-513.
• [7]Feres F,Costa RA,Abizaid A,et al.Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents:the OPTIMIZE randomized trial.JAMA,2013,310:2510-2522.
• [8]Kim BK,Hong MK,Shin DH,et al.A new strategy for discontinuation of dual antiplatelet therapy:the RESET Trial(REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation).J Am Coll Cardiol,2012,60:1340-1348.
• [9]Gilard M,Barragan P,Noryani AA,et al.Six-month versus 24-month dual antiplatelet therapy after implantation of drug eluting stents in patients non-resistant to aspirin:ITALIC,a randomized multicenter trial.J Am Coll Cardiol,2014.[Epub ahead of print]
• [10]Park SJ,Park DW,Kim YH,et al.Duration of dual antiplatelet therapy after implantation of drug-eluting stents.N Engl J Med,2010,362:1374-1382.
• [11]Park DW,Kim YH,Yun SC,et al.Comparison of zotarolimuseluting stents with sirolimus-and paclitaxel-eluting stents for coronary revascularization:the ZEST(comparison of the efficacy and safety of zotarolimus-eluting stent with sirolimus-eluting and paclitaxel-eluting stent for coronary lesions)randomized trial.J Am Coll Cardiol,2010,56:1187-1195.
• [12]Kim HK,Jeong MH,Ahn YK,et al.Comparison of outcomes between Zotarolimus-and sirolimus-eluting stents in patients with ST-segment elevation acute myocardial infarction.Am J Cardiol,2010,105:813-818.
• [13]Collet JP,Silvain J,Barthélémy O,et al,and the for the ARCTIC investigators.Dual-antiplatelet treatment beyond 1 year after drug-eluting stent implantation(ARCTIC-Interruption):a randomised trial.Lancet,2014,384:1577-1585.
• [14]Mauri L,Kereiakes DJ,Yeh RW,et al.Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents.N Engl J Med,2014,371:2155-2166.
• [15]Garratt KN,Weaver WD,Jenkins RG,et al.Prasugrel Plus Aspirin Beyond 12 Months Is Associated With Improved Outcomes After Taxus Liberte Paclitaxel-Eluting Coronary Stent Placement.Circulation,2015,131:62-73.
• [16]Elmariah S,Mauri L,Doros G,et al.Extended duration dual antiplatelet therapy and mortality:a systematic review and metaanalysis.Lancet,2014.[Epub ahead of print]